Microbot Medical Inc. Announces Issuance of a Canadian Patent Covering a Self-Cleaning Shunt
May 31, 2017 11:33 am UTC| Business
HINGHAM, Mass., May 31, 2017 -- Microbot Medical Inc. (Nasdaq:MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, announced today that the...
Microbot Medical Inc. Announces Issuance of a Canadian Patent Covering a Self-Cleaning Shunt
May 31, 2017 11:33 am UTC| Business
HINGHAM, Mass., May 31, 2017 -- Microbot Medical Inc. (Nasdaq:MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, announced today that the...
Microbot Medical Inc. Announces Issuance of a Canadian Patent Covering a Self-Cleaning Shunt
May 31, 2017 11:33 am UTC| Business
HINGHAM, Mass., May 31, 2017 -- Microbot Medical Inc. (Nasdaq:MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, announced today that the...
Elite Pharmaceuticals Granted New Patent for Abuse Deterrent Technology
May 31, 2017 11:32 am UTC| Business
NORTHVALE, N.J., May 31, 2017 -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) announced today the issuance of European Patent No. 1615623 titled “Abuse-Resistant Oral Dosage Forms and Method of...
Elite Pharmaceuticals Granted New Patent for Abuse Deterrent Technology
May 31, 2017 11:32 am UTC| Business
NORTHVALE, N.J., May 31, 2017 -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) announced today the issuance of European Patent No. 1615623 titled “Abuse-Resistant Oral Dosage Forms and Method of...
Elite Pharmaceuticals Granted New Patent for Abuse Deterrent Technology
May 31, 2017 11:32 am UTC| Business
NORTHVALE, N.J., May 31, 2017 -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) announced today the issuance of European Patent No. 1615623 titled “Abuse-Resistant Oral Dosage Forms and Method of...
Repligen to Present at Jefferies’ 2017 Global Annual Healthcare Conference
May 31, 2017 11:31 am UTC| Business
WALTHAM, Mass., May 31, 2017 -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that management will present at Jefferies’ 2017 Global Annual...
India–US Trade Pact 2026: A New Highway to a USD 500 Billion Partnership